pretomanid
Pretomanid is an antibiotic medication used for the treatment of multi-drug-resistant tuberculosis affecting the lungs.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
nitroimidazole antibioticARO:3004115
- nitroimidazole antibiotic
ARO:3004115
Chemical structure
| Molecular formula | C14H12F3N3O5 |
|---|---|
| Charge | 0 |
| Average mass | 359.26 Da |
| Monoisotopic mass | 359.07290498 Da |
| Source | PubChem · retrieved 2026-08-29 |
| InChIKey | ZLHZLMOSPGACSZ-NSHDSACASA-N |
C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F
InChI=1S/C14H12F3N3O5/c15-14(16,17)25-10-3-1-9(2-4-10)7-23-11-5-19-6-12(20(21)22)18-13(19)24-8-11/h1-4,6,11H,5,7-8H2/t11-/m0/s1
Cross-references
- pretomanid
ARO:3007535 - chembl:CHEMBL227875
- pubchem.compound:456199
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| ARO | ARO:3007535 |
pretomanid | antibioticmech:aro-b4f5ca6a06 |
2026-08-30 |
Mechanism summary
- Clinical status
- APPROVED
Resistance mechanisms
ANTIBIOTIC_TARGET_ALTERATION 1
| Determinant | ARO ID | Organism | Gene families | Evidence |
|---|---|---|---|---|
| Mycobacterium tuberculosis ddn mutation conferring resistance to nitroimidazole antibiotics | ARO:3007661 | — |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (ARO)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories